TCM

TCG Crossover Management Portfolio holdings

AUM $876M
This Quarter Return
+53.95%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$902M
AUM Growth
+$902M
Cap. Flow
+$65.2M
Cap. Flow %
7.24%
Top 10 Hldgs %
61.32%
Holding
31
New
5
Increased
2
Reduced
1
Closed
2

Top Buys

1
TRML icon
Tourmaline Bio
TRML
$26.4M
2
GPCR icon
Structure Therapeutics
GPCR
$24.7M
3
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$14.8M
4
VTGN icon
VistaGen Therapeutics
VTGN
$13.8M
5
ABVX
Abivax
ABVX
$11.8M

Top Sells

1
TSHA icon
Taysha Gene Therapies
TSHA
$14.5M
2
IMVT icon
Immunovant
IMVT
$12.9M
3
MRUS icon
Merus
MRUS
$7.07M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GPCR icon
1
Structure Therapeutics
GPCR
$1.11B
$86M 9.54%
2,109,584
+606,837
+40% +$24.7M
INBX
2
DELISTED
Inhibrx, Inc. Common Stock
INBX
$66.5M 7.38%
1,750,387
– –
ICVX
3
DELISTED
Icosavax, Inc. Common Stock
ICVX
$58.4M 6.47%
3,703,704
– –
ANTX icon
4
AN2 Therapeutics
ANTX
$30.1M
$54.9M 6.09%
2,678,209
– –
RYZB
5
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$54.1M 6%
869,908
– –
JBIO
6
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$49.8M 5.52%
2,201,274
– –
GERN icon
7
Geron
GERN
$893M
$49.3M 5.47%
23,375,839
– –
SVRA icon
8
Savara
SVRA
$567M
$47M 5.21%
10,000,000
– –
GRCL
9
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$45.3M 5.03%
4,514,786
+1,475,897
+49% +$14.8M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$9.76B
$41.6M 4.62%
179,917
– –
KALV icon
11
KalVista Pharmaceuticals
KALV
$678M
$41.6M 4.61%
3,395,495
– –
SLN
12
Silence Therapeutics
SLN
$227M
$36.6M 4.05%
2,104,875
– –
CMPS
13
Compass Pathways
CMPS
$424M
$33.8M 3.74%
3,858,000
– –
COGT icon
14
Cogent Biosciences
COGT
$1.69B
$33.1M 3.67%
5,631,042
– –
TYRA icon
15
Tyra Biosciences
TYRA
$675M
$27.5M 3.06%
1,989,103
– –
TRML icon
16
Tourmaline Bio
TRML
$601M
$26.4M 2.93%
+1,007,902
New +$26.4M
TARS icon
17
Tarsus Pharmaceuticals
TARS
$2.47B
$23.1M 2.57%
1,142,857
– –
DYN icon
18
Dyne Therapeutics
DYN
$1.92B
$21.9M 2.43%
1,650,150
– –
KURA icon
19
Kura Oncology
KURA
$686M
$20.5M 2.27%
1,423,642
– –
CNTA
20
Centessa Pharmaceuticals
CNTA
$2.25B
$16.2M 1.8%
2,040,816
– –
VTGN icon
21
VistaGen Therapeutics
VTGN
$102M
$13.8M 1.53%
+2,676,580
New +$13.8M
ABVX
22
Abivax
ABVX
$6.12B
$11.8M 1.31%
+1,100,000
New +$11.8M
CABA icon
23
Cabaletta Bio
CABA
$133M
$11.1M 1.23%
486,795
– –
TRDA icon
24
Entrada Therapeutics
TRDA
$208M
$8.83M 0.98%
584,955
– –
NRIX icon
25
Nurix Therapeutics
NRIX
$714M
$7.41M 0.82%
+717,654
New +$7.41M
1
2